Nutex Health (NASDAQ:NUTX) Stock Rating Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Nutex Health (NASDAQ:NUTX) from a buy rating to a hold rating in a report published on Saturday,Wall Street Zen reports.

A number of other analysts have also commented on NUTX. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Zacks Research cut Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. LADENBURG THALM/SH SH assumed coverage on shares of Nutex Health in a research report on Monday, October 26th. They set a “buy” rating and a $336.00 target price on the stock. Lake Street Capital reaffirmed a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Finally, B. Riley Financial reaffirmed a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $323.67.

Nutex Health Stock Down 4.7%

Shares of NUTX opened at $200.15 on Friday. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of 7.86 and a beta of 0.55. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The business’s fifty day moving average price is $203.24 and its two-hundred day moving average price is $150.70. Nutex Health has a 52 week low of $83.99 and a 52 week high of $226.16.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. The company had revenue of $210.75 million during the quarter, compared to analysts’ expectations of $215.03 million. On average, analysts predict that Nutex Health will post 26.65 earnings per share for the current year.

Insider Buying and Selling

In other Nutex Health news, Director Scott Saunders sold 203 shares of the firm’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director directly owned 400 shares in the company, valued at approximately $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Nutex Health during the 2nd quarter worth approximately $69,612,000. Winmill & CO. Inc. bought a new stake in shares of Nutex Health in the second quarter worth $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health in the second quarter worth $7,720,000. Bank of New York Mellon Corp bought a new stake in Nutex Health during the 2nd quarter worth about $3,956,000. Finally, Bridge City Capital LLC bought a new stake in Nutex Health during the 3rd quarter worth about $3,918,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.